Clinical characteristics of the patients included in the study
. | . | Moment of fetal loss, wk of amenorrhea . | . | . | . | Age, y . | . | . | . | BMI, kg/m2 . | . | . | . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | No. pregnancies, mean (range) . | Median (range) . | 10-16 . | Greater than 16 to 22 . | Greater than 22 . | Median (range) . | Younger than 25 . | 25 to younger than 30 . | 30 or older . | Median (range) . | Less than 25 . | 25 to less than 30 . | 30 or greater . | |||||||||
| All women | 1 (1-2) | 15 (10-29) | 96 | 50 | 14 | 26 (18-36) | 74 | 64 | 22 | 24.2 (21-32) | 108 | 44 | 8 | |||||||||
| AllFVL | 1 (1-2) | 15 (10-29) | 48 | 15 | 9 | 25 (18-35) | 31 | 31 | 10 | 24.8 (21.4-31) | 54 | 14 | 4 | |||||||||
| AllFIIL | 1 (1-2) | 15 (10-27) | 32 | 26 | 2 | 27 (20-34) | 28 | 22 | 10 | 23.7 (21.1-32) | 34 | 22 | 4 | |||||||||
| AllPS | 1 (1-2) | 16 (11-23) | 16 | 9 | 3 | 26 (19-36) | 15 | 11 | 2 | 24.5 (21-29.5) | 20 | 8 | 0 | |||||||||
. | . | Moment of fetal loss, wk of amenorrhea . | . | . | . | Age, y . | . | . | . | BMI, kg/m2 . | . | . | . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | No. pregnancies, mean (range) . | Median (range) . | 10-16 . | Greater than 16 to 22 . | Greater than 22 . | Median (range) . | Younger than 25 . | 25 to younger than 30 . | 30 or older . | Median (range) . | Less than 25 . | 25 to less than 30 . | 30 or greater . | |||||||||
| All women | 1 (1-2) | 15 (10-29) | 96 | 50 | 14 | 26 (18-36) | 74 | 64 | 22 | 24.2 (21-32) | 108 | 44 | 8 | |||||||||
| AllFVL | 1 (1-2) | 15 (10-29) | 48 | 15 | 9 | 25 (18-35) | 31 | 31 | 10 | 24.8 (21.4-31) | 54 | 14 | 4 | |||||||||
| AllFIIL | 1 (1-2) | 15 (10-27) | 32 | 26 | 2 | 27 (20-34) | 28 | 22 | 10 | 23.7 (21.1-32) | 34 | 22 | 4 | |||||||||
| AllPS | 1 (1-2) | 16 (11-23) | 16 | 9 | 3 | 26 (19-36) | 15 | 11 | 2 | 24.5 (21-29.5) | 20 | 8 | 0 | |||||||||
BMI indicates body mass index; AllFVL, all patients carrying the heterozygous factor V Leiden mutation; AllFIIL, all patients carrying the heterozygous factor II G20210A mutation; AllPS, all patients carrying a protein S deficiency.